NCT05772338 - Efficacy and Safety of BNP105 in the Treatment of Recurrent Aphthous Stomatitis | Biotech Hunter

Enrollment

102

Participants

Timeline

Start Date

January 22, 2024

Primary Completion Date

January 31, 2025

Study Completion Date

April 30, 2025

Conditions

Aphthous Stomatitis

Interventions

DRUG

BNP105 (25 + 25 + 15)

BNP105 oral suspension, 25 mg + 25 mg + 15 mg, oral. Up to six applications per day.

OTHER

Placebo

Placebo. Up to six applications per day.

Trial Locations (2)

NOT_YET_RECRUITING

EMS, Hortolândia

RECRUITING

Cecip Jau - Centro de Estudos Clinicos Do Interior Paulista Ltda, Jaú